Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori

被引:155
作者
Laine, L [1 ]
Estrada, R [1 ]
Trujillo, M [1 ]
Knigge, K [1 ]
Fennerty, MB [1 ]
机构
[1] Univ So Calif, Sch Med, Dept Med, Gastrointestinal Div, Los Angeles, CA 90033 USA
关键词
D O I
10.7326/0003-4819-129-7-199810010-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Proton-pump inhibitor therapy may cause false-negative results on Helicobacter pylori diagnostic testing. Objective: To determine the frequency and duration of conversion of urea breath test results from positive to negative in patients given a proton-pump inhibitor. Setting: Two urban university gastroenterology clinics. Patients: Patients infected with H. pylori who had positive results on urea breath tests. Intervention: Lansoprazole, 30 mg/d for 28 days. Measurements: The urea breath test was repeated at 28 days. If the results were negative, testing was repeated 3, 7, 14, and 28 days after completion of therapy until the results reverted to positive. Results: 31 (33%) of 93 patients in whom H. pylori was not eradicated had a negative breath test result while receiving lansoprazole. The proportions of patients whose breath test results were positive after completion of lansoprazole therapy were 91% (95% CI, 83% to 96%) at 3 days, 97% (CI, 90% to 99%) at 7 days, and 100% (CI, 96% to 100%) at 14 days. Conclusion: Patients should not receive proton-pump inhibitors for 2 weeks before receiving the urea breath test for H. pylori infection.
引用
收藏
页码:547 / 550
页数:4
相关论文
共 15 条
[1]   Non-endoscopic tests in the diagnosis of Helicobacter pylori infection [J].
Atherton, JC .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 :11-20
[2]  
BAYERDORFFER E, 1992, EUR J GASTROEN HEPAT, V4, P697
[3]  
BIASCO G, 1989, LANCET, V2, P1403
[4]  
Chey WD, 1997, AM J GASTROENTEROL, V92, P446
[5]  
Chey WD, 1996, AM J GASTROENTEROL, V91, P89
[6]  
Cutler AF, 1996, AM J GASTROENTEROL, V91, P85
[7]  
DAW MA, 1991, ALIMENT PHARM THERAP, V5, P435
[8]   EFFECT OF OMEPRAZOLE ON DUODENAL ULCER-ASSOCIATED ANTRAL GASTRITIS AND HELICOBACTER-PYLORI [J].
HUI, WM ;
LAM, SK ;
HO, J ;
LAI, CL ;
LOK, ASF ;
NG, MMT ;
LAU, WY ;
BRANICKI, FJ .
DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (05) :577-582
[9]   LANSOPRAZOLE, A NOVEL BENZIMIDAZOLE PROTON PUMP INHIBITOR, AND ITS RELATED-COMPOUNDS HAVE SELECTIVE ACTIVITY AGAINST HELICOBACTER-PYLORI [J].
IWAHI, T ;
SATOH, H ;
NAKAO, M ;
IWASAKI, T ;
YAMAZAKI, T ;
KUBO, K ;
TAMURA, T ;
IMADA, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) :490-496
[10]  
Kolt SD, 1997, GASTROENTEROLOGY, V112, pA180